Effects of Intensive cART During Acute/Early HIV Infection
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This trial will investigate the efficacy and safety of intensified antiretroviral treatment
that includes raltegravir and maraviroc during the early stages of HIV infection. With the
proven efficacy of these antiviral drugs in pre- and post-clinical trials, we would like to
investigate the ability of the combination of raltegravir and maraviroc plus a standard HAART
backbone to further decrease the viral load in acutely infected treated HIV infected
individuals.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Toronto
Collaborators:
Maple Leaf Medical Clinic St. Michael's Hospital, Toronto Unity Health Toronto